Ipilimumab in Squamous Non-Small Cell Lung Cancer
2 Views
administrator
07/14/23
The panelists, Benjamin Levy, MD; Paul K. Paik, MD; and Edward S. Kim, MD, FACP, assess clinical trial results of the CTLA-4 antibody ipilimumab in squamous non-small cell lung cancer.
-
Category
Show more
Facebook Comments
No comments found